Table 3 Comparison of serum and cerebrospinal fluid CXCL13 levels in NMO and MS patients with EDSS scores ≥ 3.5 and EDSS scores < 3.5.

From: Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica

Observation indicators

EDSS score ≥ 3.5 group

EDSS score<3.5 group

t

P

n

43

41

-

-

Serum CXCL13 (pg/ml)

85.12 ± 8.50

69.29 ± 7.78

8.895

< 0.001

Cerebrospinal fluid CXCL13 (pg/ml)

23.11 ± 8.09

13.16 ± 7.16

5.955

< 0.001